Northwestern Medicine scientists have uncovered a surprising link between a tiny cellular engine and the way cancer cells ...

Researchers at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine have been awarded more than $15 ...

Among men worldwide, prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths. As the world's population ages, the number of prostate cancer patients is expected ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about ...

MyRisk TestSALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular ...

They found that the young mice had three times more cancer than the older ones. The young mice also had about three times as ...

Pancreatic cancer has a reputation for being one of the deadliest malignancies, in part because it is often diagnosed late and progresses quickly. While genetics and age play a role, a growing body of ...

Mainz Biomed will present its current flagship product, ColoAlert®, a molecular stool-based screening test for the early detection of colorectal cancer, as well as further upcoming diagnostic ...

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced MyRisk®Hereditary Cancer Test —the gold ...